Cargando…

The application of CGF combined with GBR in alveolar bone increment for patients with anxiety disorder: A rare case report and literature review

RATIONALE: Selective serotonin reuptake inhibitors (SSRIs), one of the commonly used anti-anxiety drugs, may have impacts on bone metabolism and potentially lead to drug-induced osteoporosis. The traditional approach of oral implantation in individuals with both anxiety disorder and drug-induced ost...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhixin, Yang, Chao, Wang, Jinrong, Zheng, Kaiyue, Luo, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637472/
https://www.ncbi.nlm.nih.gov/pubmed/37960737
http://dx.doi.org/10.1097/MD.0000000000035905
_version_ 1785146505789702144
author Li, Zhixin
Yang, Chao
Wang, Jinrong
Zheng, Kaiyue
Luo, Wen
author_facet Li, Zhixin
Yang, Chao
Wang, Jinrong
Zheng, Kaiyue
Luo, Wen
author_sort Li, Zhixin
collection PubMed
description RATIONALE: Selective serotonin reuptake inhibitors (SSRIs), one of the commonly used anti-anxiety drugs, may have impacts on bone metabolism and potentially lead to drug-induced osteoporosis. The traditional approach of oral implantation in individuals with both anxiety disorder and drug-induced osteoporosis poses a significant challenge. To address this issue, concentrated growth factor (CGF) has been utilized in patients undergoing concurrent alveolar ridge augmentation during oral implantation, resulting in favorable clinical outcomes. Consequently, combining CGF with guided bone regeneration (GBR) in alveolar bone increment may represent a promising new surgical approach for such patients. In this report, we present a case study of a 25-year-old male with anxiety disorder and drug-induced osteoporosis, in who CGF combined with GBR was employed in alveolar bone increment. PATIENT CONCERNS: This article reports the case of a 25-year-old male who underwent cone beam computed tomography (CBCT) due to the absence of his right lower second molar for a period of six months. The CBCT scan revealed significant bone defects, which were attributed to the tooth loss and prolonged use of anti-anxiety drugs. Consequently, the patient sought medical assistance from our department. DIAGNOSES: Based on the patient's self-report, he was diagnosed with an anxiety disorder. Additionally, the CBCT scan confirmed the loss of the right mandibular second molar and revealed the presence of dental irregularity and an alveolar bone defect. INTERVENTIONS: During the patient's course of treatment with anti-anxiety medication, a combination of CGF and GBR was employed for the simultaneous implantation of the missing right mandibular second molar, along with bone augmentation. OUTCOMES: The patient had a follow-up visit two weeks after the surgical procedure, and the wound in the operation area had healed satisfactorily. Six months later, CBCT images revealed excellent osseointegration. The buccal and lingual width of the alveolar bone measured 6.95mm, which was an increase of 1.35mm compared to the pre-implantation stage. LESSONS: This article presents a case study in which CGF combined with GBR were utilized to address alveolar bone augmentation during the implantation phase in patients taking anti-anxiety medication. The results demonstrated that CGF combined with GBR, as a cutting-edge platelet concentrate technique, could effectively stimulate bone tissue proliferation in individuals who have been on long-term anti-anxiety medication, specifically in oral implant areas. This approach can help prevent poor osseointegration, promote higher osseointegration rates, and facilitate wound healing.
format Online
Article
Text
id pubmed-10637472
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-106374722023-11-15 The application of CGF combined with GBR in alveolar bone increment for patients with anxiety disorder: A rare case report and literature review Li, Zhixin Yang, Chao Wang, Jinrong Zheng, Kaiyue Luo, Wen Medicine (Baltimore) 5900 RATIONALE: Selective serotonin reuptake inhibitors (SSRIs), one of the commonly used anti-anxiety drugs, may have impacts on bone metabolism and potentially lead to drug-induced osteoporosis. The traditional approach of oral implantation in individuals with both anxiety disorder and drug-induced osteoporosis poses a significant challenge. To address this issue, concentrated growth factor (CGF) has been utilized in patients undergoing concurrent alveolar ridge augmentation during oral implantation, resulting in favorable clinical outcomes. Consequently, combining CGF with guided bone regeneration (GBR) in alveolar bone increment may represent a promising new surgical approach for such patients. In this report, we present a case study of a 25-year-old male with anxiety disorder and drug-induced osteoporosis, in who CGF combined with GBR was employed in alveolar bone increment. PATIENT CONCERNS: This article reports the case of a 25-year-old male who underwent cone beam computed tomography (CBCT) due to the absence of his right lower second molar for a period of six months. The CBCT scan revealed significant bone defects, which were attributed to the tooth loss and prolonged use of anti-anxiety drugs. Consequently, the patient sought medical assistance from our department. DIAGNOSES: Based on the patient's self-report, he was diagnosed with an anxiety disorder. Additionally, the CBCT scan confirmed the loss of the right mandibular second molar and revealed the presence of dental irregularity and an alveolar bone defect. INTERVENTIONS: During the patient's course of treatment with anti-anxiety medication, a combination of CGF and GBR was employed for the simultaneous implantation of the missing right mandibular second molar, along with bone augmentation. OUTCOMES: The patient had a follow-up visit two weeks after the surgical procedure, and the wound in the operation area had healed satisfactorily. Six months later, CBCT images revealed excellent osseointegration. The buccal and lingual width of the alveolar bone measured 6.95mm, which was an increase of 1.35mm compared to the pre-implantation stage. LESSONS: This article presents a case study in which CGF combined with GBR were utilized to address alveolar bone augmentation during the implantation phase in patients taking anti-anxiety medication. The results demonstrated that CGF combined with GBR, as a cutting-edge platelet concentrate technique, could effectively stimulate bone tissue proliferation in individuals who have been on long-term anti-anxiety medication, specifically in oral implant areas. This approach can help prevent poor osseointegration, promote higher osseointegration rates, and facilitate wound healing. Lippincott Williams & Wilkins 2023-11-10 /pmc/articles/PMC10637472/ /pubmed/37960737 http://dx.doi.org/10.1097/MD.0000000000035905 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 5900
Li, Zhixin
Yang, Chao
Wang, Jinrong
Zheng, Kaiyue
Luo, Wen
The application of CGF combined with GBR in alveolar bone increment for patients with anxiety disorder: A rare case report and literature review
title The application of CGF combined with GBR in alveolar bone increment for patients with anxiety disorder: A rare case report and literature review
title_full The application of CGF combined with GBR in alveolar bone increment for patients with anxiety disorder: A rare case report and literature review
title_fullStr The application of CGF combined with GBR in alveolar bone increment for patients with anxiety disorder: A rare case report and literature review
title_full_unstemmed The application of CGF combined with GBR in alveolar bone increment for patients with anxiety disorder: A rare case report and literature review
title_short The application of CGF combined with GBR in alveolar bone increment for patients with anxiety disorder: A rare case report and literature review
title_sort application of cgf combined with gbr in alveolar bone increment for patients with anxiety disorder: a rare case report and literature review
topic 5900
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637472/
https://www.ncbi.nlm.nih.gov/pubmed/37960737
http://dx.doi.org/10.1097/MD.0000000000035905
work_keys_str_mv AT lizhixin theapplicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview
AT yangchao theapplicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview
AT wangjinrong theapplicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview
AT zhengkaiyue theapplicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview
AT luowen theapplicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview
AT lizhixin applicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview
AT yangchao applicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview
AT wangjinrong applicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview
AT zhengkaiyue applicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview
AT luowen applicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview